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Abstract
Background:  The power of DNA microarrays derives from their ability to monitor the
expression levels of many genes in parallel. One of the limitations of such powerful analytical tools
is the inability to detect certain transcripts in the target sample because of artifacts caused by
background noise or poor hybridization kinetics. The use of base-modified analogs of nucleoside
triphosphates has been shown to increase complementary duplex stability in other applications, and
here we attempted to enhance microarray hybridization signal across a wide range of sequences
and expression levels by incorporating these nucleotides into labeled cRNA targets.
Results: RNA samples containing 2-aminoadenosine showed increases in signal intensity for a
majority of the sequences. These results were similar, and additive, to those seen with an increase
in the hybridization time. In contrast, 5-methyluridine and 5-methylcytidine decreased signal
intensities. Hybridization specificity, as assessed by mismatch controls, was dependent on both
target sequence and extent of substitution with the modified nucleotide. Concurrent incorporation
of modified and unmodified ATP in a 1:1 ratio resulted in significantly greater numbers of above-
threshold ratio calls across tissues, while preserving ratio integrity and reproducibility.
Conclusions: Incorporation of 2-aminoadenosine triphosphate into cRNA targets is a promising
method for increasing signal detection in microarrays. Furthermore, this approach can be
optimized to minimize impact on yield of amplified material and to increase the number of
expression changes that can be detected.
Background
DNA microarrays have been widely adopted in genomics
because of the their ability to simultaneously examine the
expression levels of thousands of genes. As a result, the
scope of applications for microarrays has broadened rap-
idly, from drug discovery [1], to classification of cancers
[2–4] and analysis of splice variants [5]. Novel analytical
tools have been constructed to address every component
of the microarray experiment and optimize performance
[6]. However, ideal systems with maximized sensitivity
and data reproducibility have not been achieved. One ap-
proach to enhance sensitivity in microarrays, using a nov-
el signal amplification technique, has recently been
reported [7]. Another approach is to increase the affinity
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of a probe (nucleic acid present on the array) for its target
through modifications to the length [8], chemistry [9], or
physical structure [10] of the probe.
Naturally occurring analogs of purine and pyrimidine bas-
es have been examined extensively for their ability to in-
crease the thermodynamic stability of DNA:DNA and
DNA:RNA duplexes [11–15]. Among these are 2-ami-
noadenine also known as diaminopurine (DAP), which is
found in S-2L cyanophage DNA [16], 5-methyl uracil
(MeU), and 5-methyl cytidine (MeC). Previous studies
have shown the ribonucleoside triphosphate derivatives
of modified bases to be effectively incorporated by RNA
polymerases [17,18], which make them an excellent sub-
strate for use in microarray sample preparations requiring
amplification through in vitro transcriptions (IVTs).
Due to their effects on duplex stability and secondary
structures and their lack of replication by DNA polymer-
ases, modified nucleotides have recently been exploited in
a variety of technologies in molecular biology and genom-
ics. For example, 2'-O-methyl ribonucleotides and 5-(1-
propynyl)pyrimidines have been chemically incorporated
into oligonucleotides which were used to detect telomeric
repeat sequences in fluorescence in situ hybridization
(FISH) assays [19]. Furthermore, chimeric primers con-
taining deoxynucleotides and 2'-O-methyl ribonucle-
otides have been used to eliminate artifacts, produced by
exponential amplification of minor side-products, in cy-
cle sequencing [20].
Recently, studies employing DNA arrays have also exam-
ined the use of modified nucleotides such as DAP, 5-bro-
modeoxyuridine, and 2'-O-methylthymidine in the probe
[21,22]. An alternative method to increase the probe-tar-
get affinity is to incorporate the modified ribonucleotide,
as the triphosphate derivative, during the IVT process so
that the cRNA produced has the desired level of substitu-
tion of the corresponding unmodified nucleotide. Such
an approach has been demonstrated in a study which ap-
plied these modified cRNA products to high density oligo-
nucleotide arrays [23]. However, that study measured the
signal when amplifying a specific gene rather than a ge-
nome-wide approach. A genome-wide amplification, cou-
pled with the incorporation of modified nucleotides,
permits measurement of every transcript in the sample. To
our knowledge, no systematic studies have been per-
formed examining the incorporation of modified ribonu-
cleotide triphosphates into cRNA, yield of amplified
material, effects on hybridization intensities and repro-
ducibility, and the impact on the differential expression
ratios. It will not be possible to gauge the full potential,
advantages, and disadvantages until such studies have
been completed.
In this study, we investigated the possibility that incorpo-
ration of modified nucleotides into complementary RNA
(cRNA) target samples could increase signal intensity on
the Motorola Codelink™ Expression microarray platform.
The ratios of modified to unmodified nucleoside triphos-
phates (NTPs) were varied in each target synthesis in order
to measure the range of effects on cRNA yield, specific ac-
tivity of target sample, hybridization signals, and differen-
tial expression ratios. Our results suggest that
incorporation of 2-aminoadenosine (DAP) triphosphate
into target cRNA samples may increase hybridization sig-
nal intensity for a wide variety of RNA:DNA hybrid du-
plexes. In contrast, 5-methyluridine and 5-methylcytidine
had detrimental effects on signal intensities. Hybridiza-
tion specificity was dependent on both target sequence
and extent of substitution with the modified nucleotide.
Concurrent incorporation of modified and unmodified
ATP in a 1:1 ratio resulted in significantly greater numbers
of above-threshold ratio calls across tissues, while preserv-
ing ratio integrity and reproducibility.
Results
Effect of modified nucleotides on cRNA yield and assess-
ment of their incorporation and biotin-11-UTP incorpora-
tion
Although DAP, MeC, and MeU were tolerated by T7 RNA
polymerase, incorporation of these analogs into our IVT
reaction cocktails reduced the yields of amplified cRNA.
The magnitude of the decrease was 20–30% and depend-
ed on RNA tissue source and the NTP modification. How-
ever, within the context of our pre-established assay
conditions (a single color, single sample per array system
using ten micrograms of cRNA), enough cRNA was gener-
ated from each IVT reaction to perform hybridizations in
triplicate. Thus, we were able to normalize input amounts
of cRNA for each condition tested in order to quantitative-
ly compare relative changes due to each respective modi-
fication. In these experiments, we generated cRNA from
five micrograms of total RNA and did not explore the im-
pact on yield when smaller or larger amounts of input to-
tal RNA are used.
We next determined how well the modified NTPs were in-
corporated by the T7 RNA polymerase and whether incor-
poration of biotinylated UTP was altered due to the
presence of these modified NTPs. To address these ques-
tions, we used an analytical method developed in our lab-
oratory and described in a previous study [24]. Briefly, the
complex cRNA is digested with P1 nuclease and calf intes-
tinal phosphatase and applied to a high performance liq-
uid chromatography (HPLC) column to separate the
nucleosides, followed by an absorbance measurement at
260 nm. As seen in Figure 1A, when only the unmodified
NTPs are incorporated during the IVT, there is good sepa-
ration of the individual nucleosides. Furthermore, as re-BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
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ported earlier [24], using the extinction coefficients and
integrating the area under these peaks, there are approxi-
mately equal amounts of each of the four nucleosides.
When DAP was added at a 1:1 molar ratio to the adenos-
ine, the chromatogram showed incorporation of DAP into
the cRNA, and this level of incorporation appeared to be
equivalent to the level of incorporation of adenosine (Fig-
ure 1B). Moreover, when the adenosine was fully substi-
tuted by the DAP in the IVT reaction cocktail, only a peak
corresponding to the DAP was detected (Figure 1C), and
this peak was approximately equal in area to that of the
adenosine in the control situation. Similarly, when MeC
was fully substituted for cytidine in the IVT reaction cock-
tail, only a peak corresponding to the MeC was detected
(Figure 1D), and this peak was approximately equal in
area to that of the cytidine in the control situation. In con-
trast, we were unable to examine incorporation levels of
the MeU because the MeU peak was eluted at approxi-
mately the same time as the guanosine peak (data not
shown). It is important to note that these analyses used
the complex cRNA and represent a global, average view of
the incorporation. Incorporation may differ somewhat
depending on the sequence, structure, or expression level
of the nascent RNA transcript. We therefore incorporated
each of these modified nucleotides into a unique bacterial
transcript, generated by run off transcription from a plas-
mid into which the gene was cloned. When this transcript
was digested and applied to the HPLC, we found similar
results as seen with the complex cRNA (data not shown).
We conclude that these modified nucleotides are incorpo-
Figure 1
HPLC analysis of digested cRNA demonstrates incorporation of modified nucleotides and their resolution from unmodified
counterparts. Absorbance profiles at 260 nm are shown for (A) control, (B) 1:1 DAP:A, (C) fully substituted DAP, and (D) fully
substituted MeC conditions. Proportions of each nucleoside were calculated using peak areas and extinction coefficients. The
peaks for cytosine, uridine, guanosine, and adenosine show up in the unmodified control sample (A) at approximately 5.0, 7.2,
12.6, and 15.6 min, respectively.
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rated during the IVT reaction at ratios which are reflective
of the input ratio to the unmodified counterpart.
Because the sensitivity and reproducibility of microarrays
depends on the specific activity of target cRNA, we also
wanted to determine if adding modified NTPs to the IVT
changed the incorporation rate of biotin-11-UTP. This bi-
otinylated nucleotide is used in our biotin-streptavidin-
Alexa647 conjugate detection system. We found that the
level of biotinylated uridine, detected at 294 nm after di-
gestion and application to the HPLC, was unaffected by
the presence of any of the modified NTPs in the IVT reac-
tion cocktail (data not shown). Moreover, analysis of in-
dividual transcripts, which were enzymatically digested
into mononucleosides, showed equivalent incorporation
rates of biotin-11-UTP for both control samples and target
samples containing modified ATP.
Lastly, we examined what effect, if any, incorporation of
modified NTPs had on the length of the amplified cRNA.
Transcript size was determined by running samples on an
Agilent 2100 BioAnalyzer. No difference was observed for
either individual transcripts or complex samples in modi-
fied versus unmodified ATP samples (data not shown).
Effect of modified nucleotides on hybridization signals and 
specificity
We next determined the effect of these modified NTPs on
hybridization intensities. After hybridization, scatter plots
of hybridization intensities were generated comparing
those intensities generated from unmodified cRNA (con-
Figure 2
Modified purines and pyrimidines show differential effects on hybridization intensities when incorporated into cRNA targets.
Modified and unmodified (Control) samples were normalized for concentration, fragmented, and hybridized onto Human Uni-
set I microarrays in duplicate, except for 5-methyl CTP samples, which were hybridized in duplicate onto arrays with 1100
probes spotted in 6-fold redundancy. Average signal intensities after background subtraction were plotted for all probes of the
Human Uniset I array for the control samples versus (A) control, (B) fully DAP-substituted, (C) 1:1 substituted DAP, (D) fully
meC-substituted, and (E) fully MeU-substituted.
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trol) to either the duplicate control hybridization or to in-
tensities generated from cRNA where one of the modified
NTPs was incorporated. The comparison of control versus
control (Figure 2A) illustrates that, if hybridization inten-
sities are equal in the two conditions, the points should lie
on the diagonal. Complete substitution of unmodified
ATP with DAP (Figure 2B) produced greater increases
overall in individual probe signals than the target sample
containing a 1:1 ratio of DAP to unmodified ATP (Figure
2C), as would be expected if DAP incorporation increased
the DNA:RNA hybrid duplex stability. A quantitative esti-
mation of assay performance increase can be derived from
the median probe signal on each microarray. Although
Figure 2B and 2C show that increases in signal intensity
are not linear for all probe sequences, median slide inten-
sity across sets of duplicate hybridizations for two differ-
ent tissues (human embryonic kidney and Burkitt's
lymphoma) increased an average of 40% +/- 7% and 99%
+/- 6% for the 1:1 DAP:A and all DAP conditions, respec-
tively, over the unmodified control sample. However, Fig-
ure 2B also shows that full substitution of adenosine by
DAP reduced the hybridization signals for many of the
probes, generating a bowing towards the unmodified con-
trol condition and suggesting a duplex destabilizing effect
of complete DAP substitution in certain sequence contexts
[11,23]. On a global scale, such a high incidence of probes
with reduced hybridization signals may limit the useful-
ness of the complete DAP substitution. Of particular inter-
est is the observation that the number of probes which
have increased signal and the degree to which their signals
are increased are highest at the lower end of the signal
range. In contrast, both of the modified pyrimidine tri-
phosphates (MeC and MeU) tested resulted in a decrease
in overall signal intensities for nearly all of the probes test-
ed when compared against unmodified control samples
(Figures 2D &2E). However, data points on the right of
the diagonal in figures 2D and 2E also show that for a frac-
tional set of target-probe pairs, substitution with MeC and
MeU increased hybridization signal relative to the un-
modified control. Those probes whose signal intensities
were increased at least two-fold are summarized in Table
1. As Table 1 shows, for a number of transcripts substitu-
tion with MeC or MeU may potentially augment hybridi-
zation signals more so than even DAP. This may prove
useful for target samples containing very low concentra-
tions of these particular transcripts. Nevertheless, because
our goal was to utilize modifications that would increase
hybridization signals for the vast majority of target-probe
duplexes, we subsequently focused our efforts on the sam-
ples containing DAP.
We next determined whether the increases in signal inten-
sity observed with DAP substitution were similar in mag-
nitude to those observed when the hybridization time is
increased. We therefore hybridized two micrograms of
cRNA with no modifications or two micrograms with DAP
at a 1:1 molar ratio to adenosine for 18 hours and hybrid-
ized two micrograms of cRNA with no modifications for
42 hours. We generated two scatterplot and overplayed
these scatterplot on each other (Figure 3A). The first scat-
terplot compares the intensities of the 18 hour control
with those of the 42 hour control (orange signals). The
second scatterplot compares the intensities of the 18 hour
control with those of the DAP-modified cRNA (blue sig-
nals). The longer hybridization time increases the median
signal intensity by 47% +/- 2%. The increase is more pro-
Table 1: Percent signal change due to nucleotide substitution.
Relative percent change
Probe Name MeC MeU 1:1 DAP:A
AI936591 108 -38 27
AB029001 110 -7 112
U90544 113 -19 540
AA707570 115 -7 259
AK000445 116 22 23
AF054506 121 -36 47
AB007891 127 -16 117
D42045 138 62 35
AB006190 146 -28 481
AI935557 166 25 2
NM_006794 168 -20 1623
AB028946 168 -24 351
AK000601 179 51 451
AB020710 198 90 165
AK000527 230 -33 93
AI742085 246 5 41
AF017789 269 601 -44
AK001962 279 257 4
AF038661 291 -44 445
AB037797 301 295 279
AF035121 314 40 10
AF016369 332 324 149
AB034695 346 -22 363
U15932 377 66 43
AK001933 380 219 237
AJ223352 465 545 54
AF227899 559 106 603
AK000286 821 -57 922
AF052093 885 587 177
L77701 2356 1278 284
AL137493 4256 -37 2977
D86956 5999 2857 1367
MeC and MeU substitution increases signal intensities for a small 
number of probes. Relative percent change was calculated by the 
equation: 100 * (modified sample signal - control sample signal) / con-
trol sample signal. Relative change for these probes due to 1:1 DAP:A 
substitution is also given as reference.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
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nounced for the medium and high signals. As shown be-
fore, the DAP-modified cRNA generated hybridization
signals which were also increased relative to the 18 hour
control hybridization. However, the increase seemed
more pronounced for the low and medium signals. We
conclude that both DAP modification and an increased
hybridization time can affect the hybridization reaction
but in very different ways.
Because of the differential effects of increased hybridiza-
tion time and DAP substitution on low and high express-
ers, we wanted determine whether the increases seen of
using both DAP modification and an extended hybridiza-
tion time could be additive. We therefore hybridized un-
modified (control) cRNA for 18 hours and a DAP-
modified cRNA for 42 hours (Figure 3B). The median
slide intensity increased by 110% +/- 17%, which is ap-
proximately double the increase seen with either the 1:1
DAP:A or the longer hybridization time by themselves.
When all of the approximately 9,000 probes are divided
into three equally sized bins representing low, medium,
and high expressers according to their respective signal in-
Figure 3
Effects of DAP substitution are similar, and additive, to those seen with an increased hybridization time. (A) Comparison of
intensities obtained with unmodified cRNA hybridized for 18 hours versus partially DAP-modified cRNA for 18 hours (blue
data points) transposed on a comparison of intensities obtained with unmodified cRNA hybridized for 18 hours versus
unmodified cRNA hybridized for 42 hours (orange data points). (B) Comparison of intensities obtained with unmodified cRNA
hybridized for 18 hours versus partially DAP-modified cRNA hybridized for 42 hours. (C) Plot showing the relative increases
with respect to the 18 hour, unmodified control for increased hybridization time (18 hour  42 hour), 1:1 DAP:A substitution,
and a combination of increased hybridization time/DAP substitution. The total number of probes was divided into three equally
sized bins according to their signal intensities, with the bins representing low, medium, and high expressers. Relative percent
increases for each probe were derived from the equation: 100 * (modified sample signal [time, DAP, or combination of both] -
control sample signal) / control sample signal, and are shown with standard deviation error bars.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
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tensities, the effects of increased hybridization time and
DAP become very evident (Figure 3C). Figure 3C shows
that the relative increases in signal intensities due to in-
creased hybridization time are biased towards the medi-
um and high expressers, with signals increasing an average
of 48% and 84%, respectively, whereas increases due to
DAP substitution are more pronounced for low and medi-
um expressers (57% and 81% increase, respectively). To-
gether, the two modifications of increased hybridization
time and DAP substitution can be used in concert to am-
plify signal intensities for the entire range of probe signals,
and as figure 3C indicates, these boosts in signals are ap-
proximately additive for the 42 hour, DAP-containing
samples.
We next determined the effect of modified NTPs on hy-
bridization specificity (the ability to distinguish sequenc-
es up to a certain homology). We addressed this issue by
designing probes which had one to four adjacent, central-
ly located mismatches and comparing hybridization sig-
nals generated from these mismatched probes to signals
generated from their corresponding perfect matches. In
the control situation (hybridization of unmodified cR-
NA), the hybridization intensity decreased as the number
of mismatches increased, with two mismatches generally
destabilizing the duplex sufficiently to reduce the hybrid-
ization signal to 0% of the parent signal. There was one ex-
ception (Figure 4C) where, even in the presence of four
mismatches, the signal was not reduced below 60% of the
Figure 4
Mismatch discrimination of DAP- or MeC-substituted and control samples. Specificity was determined by introducing single or
multiple adjacent, centrally located mismatches in several test probes. Signal intensities of mismatch (MM) probes are plotted
as a function of the percent of the perfect match (PM) control for unmodified (diamonds), partially DAP-modified (triangles),
fully DAP-substituted (boxes), and fully-MeC-substituted (x) cRNA targets for the transcripts corresponding to the following
accession numbers: (A) (X79067), (B) (AF067139), (C) (Z83844), and (D) (NM_004323).BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
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parent signal. This signal was low in the perfect match
and, therefore, this situation most likely reflects a lower-
ing to the noise levels. In fact, the signal was lowered to
below threshold levels in the presence of mismatches.
When equimolar ratios of DAP and unmodified ATP were
incorporated into the cRNA target (1:1 DAP:A), specificity
was not significantly affected in two of the four probe se-
quences (Figure 4A and 4B). However, in one probe se-
quence (Figure 4C), specificity was enhanced. For this test
probe, the unmodified sample produced unusually high
signals for base mismatches. Nevertheless, other groups
have seen similar improvements in mismatch discrimina-
tion with diaminopurine-containing oligo mers for differ-
ent applications [13]. A fourth probe sequence
demonstrated a smaller destabilizing effect of a single
mismatch with the partially modified cRNA compared to
the control (Figure 4D). In this sequence, the hybridiza-
tion was reduced to the same extent with three mismatch-
es using either the control or partially modified cRNA.
Full substitution of adenosine by DAP showed varied ef-
fects on specificity in the four different probe sequences.
In two of the probe sequences, the fully modified cRNA
behaved similarly to the control cRNA (Figures 4A and
4B). In a third probe sequence, the specificity improved
for the fully modified cRNA, as it did for the partially
modified cRNA (Figure 4C). The improvement in specifi-
city for this probe depended on the extent of DAP modifi-
cation. In a fourth probe sequence, the fully modified
cRNA showed a dramatic decrease in specificity with one-
or two-base mismatches, although three mismatches re-
duced the hybridization intensity to ~10% of that of the
perfect match. The loss in specificity for this probe se-
quence also depended on the extent of DAP modification,
with one, two, or three mismatches required to reduce the
hybridization intensity to ~ 10% for the control, partially
modified, and fully modified, respectively, cRNA. A fifth
test probe showed hybridization signal intensity below
the negative control threshold in both the control and
modified ATP samples, suggesting either an absence of the
transcript from the target sample or abundance too low to
quantify (data not shown). Repeat experiments with
cRNA containing modified ATP supported the general
specificity trend: unmodified ATP > 1:1 DAP:A > all DAP
(data not shown). Attempts to increase specificity in the
all DAP condition by raising the temperature during hy-
bridization from 37°C to 42°C or 47°C were unsuccessful
(data not shown). Others have been able to distinguish se-
quences of up to 90% homology [6] using the same plat-
Figure 5
Correlation of kidney to lymphoma differential expression ratios using partially DAP-modified and unmodified control samples.
Duplicate hybridizations were performed for each sample, resulting in four possible calls for kidney to lymphoma ratios for
each probe (i.e., K1:L1, K1:L2, K2:L1, K2:L2). Data plotted are the average kidney to liver ratio for the four calls on both axes.
0.0001
0.001
0.01
0.1
1
10
100
1000
0.001 0.01 0.1 1 10 100 1000
 Average Ratio 1:1 DAP:A
A
v
e
r
a
g
e
 
R
a
t
i
o
 
C
o
n
t
r
o
l
 
y=1.13x– 0.095            
R = 0.95BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
Page 9 of 15
(page number not for citation purposes)
form (3-base mismatch/ 30-mer oligonucleotide signal
near or below negative control threshold), and we support
their findings here with the control and 1:1 DAP:A condi-
tion. The fully MeC-substituted cRNA targets were exam-
ined with respect to specificity in two test sequences
(Figures 4B and 4D). In one test sequence (Figure B), the
fully MeC-substituted cRNA targets behaved nearly identi-
cally to the partially DAP-substituted targets. In the other
test sequence (Figure 4D), the MeC-substituted cRNA be-
haved nearly identically to the unmodified cRNA target
and showed better specificity than that of the partially
DAP-substituted cRNA target with respect to the effect of
one mismatch. We conclude that the specificity of fully
MeC-substituted cRNA and partially DAP-substituted
cRNA targets are, for the most part, equivalent and essen-
tially no loss in specificity (as determined by the effect of
two mismatches) is observed with these modified targets.
An additional metric of specificity on the Codelink bioar-
rays is the use of 54 negative control bacterial probes spot-
ted in 4X redundancy, which were designed and
empirically shown not to cross hybridize to human tran-
scripts [6]. While the all DAP condition resulted in an in-
crease in the hybridization intensity for three of the
negative control probes, the 1:1 DAP:A condition pro-
duced lower background signals similar to those of the
unmodified control (data not shown). Thus, increases in
hybridization signal intensities in the 1:1 DAP:A condi-
tion are attributable to specific modified cRNA target/
DNA probe interactions. We conclude that partial substi-
tution of adenosine with DAP does not significantly com-
promise specificity and was, therefore, investigated
further.
Effect of DAP incorporation on differential expression ra-
tios
Ultimately, the goal of any global expression profiling sys-
tem measuring relative transcript abundance is to accu-
rately and reproducibly determine the changes in
expression levels between different target samples. We
therefore determined if the increases in signal intensity
caused by DAP incorporation had an effect on differential
ratio calls. Kidney and lymphoma cRNA samples contain-
ing either no modified NTPs or 1:1 DAP:A were hybrid-
ized in duplicate to Human Uniset I arrays; average kidney
to lymphoma ratios were calculated and plotted (Figure
5) after removing signal outliers defined as a two-fold dif-
ference between replicates. Differential expression ratios
demonstrate very good correlation between the unmodi-
fied control sample and the 1:1 DAP:A sample (r = 0.95)
on the Human Uniset I microarray.
In addition to investigating the correlation of the differen-
tial expression ratios generated from modified and un-
modified targets, we determined whether DAP
incorporation affected the variability of the ratio calls.
One method to measure microarray reproducibility is by
calculating the coefficients of variation (CVs) for each rep-
licate probe across arrays. Likewise, CVs can also be calcu-
lated for multiple ratio calculations across different tissue
samples. Figure 6 shows a plot of the CVs of the ratios as
a function of the mean ratios for all of the data points, re-
gardless of the intensity level of the probe. Consistent with
earlier findings [6], the majority of the CVs in the of the
kidney to lymphoma ratios are below 30%, with an aver-
age of 13.2%, and the variability increases as the ratio ap-
proaches unity for the unmodified targets (Figure 6A).
Figure 6B shows that the 1:1 DAP:A condition produces
ratios with similar overall variability (average CV of
12.4%) compared to the unmodified control targets.
When the CVs in the ratios generated using either the con-
trol or partially modified cRNA are binned according to
the magnitude of the CV, the partially modified cRNA
generates more CVs in the less than 20% bins (Figure 6C).
These data demonstrate that the low variability in ratio
calls that we are able to routinely obtain [6] are main-
tained during DAP incorporation. However, a closer in-
spection of the ratios in Figures 6A and 6B reveals that a
possible caveat of DAP use is a slight compression of ra-
tios along the entire range of calls. This compression is
also observed when the observed ratio is binned accord-
ing to the magnitude of the fold change (Figure 6D). The
partially modified cRNA generates more ratios in the one
to 1.5 fold change bin and fewer ratio changes in the other
bins. This compression is not significant but also mani-
fests itself in the slope of the correlation line in Figure 5.
The slope of this line was found to be greater than unity.
The differential expression ratios calculated when using
DAP (Figures 5 and 6) suggest that incorporation of DAP
has little effect on correlation and reproducibility of ratio
calls between tissues. However, the ability to accurately
discriminate between signals due to true hybridization
events and what may be considered background noise is
paramount to making accurate differential assessments. A
lower limit of detection was previously defined using our
platform by developing a negative control threshold in or-
der to assign a confidence level to such signal or noise
queries [6]. Briefly, this threshold was determined by tak-
ing the mean signal of bacterial negative control probes
mentioned above (minus a 10% trim to account for weak
cross hybridization of high expressers or for true hybridi-
zation to sequences not in the database) and adding three
standard deviations (99.7% confidence). Using only
probes that were at or above the negative control thresh-
old in both tissues, we observed a significantly greater
number of probes in the 1:1 DAP:A sample for which we
could confidently assign a ratio (Figure 7). As Figure 7
shows, samples containing DAP generated over 400 more
above-threshold ratios than the control samples contain-BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
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ing only unmodified NTPs. Most of these ratios identified
only in the 1:1 DAP:A sample were small in magnitude,
with fold changes between 1.1 and 1.9.
Discussion
The effect of modified NTPs on hybridization intensities
Two important issues for identifying differentially ex-
pressed genes using DNA microarrays are 1) methods to
increase signal intensity and 2) the ability to accurately
separate true hybridization signals from background
noise at the low end of the signal dynamic range. In this
study, we utilized modified nucleoside triphosphates with
the aim of enhancing hybridization signal intensity across
a wide range of probe sequences. Modified ribo- and de-
oxyribonucleoside analogs have been used in a variety of
applications [12–14], but their use has been limited in the
field of microarrays [23]. We demonstrate that 2-ami-
noadenosine or 2,6-diaminopurine (DAP), an analog of
adenosine, significantly increases signal intensity for a
wide range of probe sequences, whereas C-5 methylated
pyrimidine analogs of cytosine and uridine decreased sig-
nal intensities across the entire range of probe sequences
on our platform (Figure 2).
Although incorporation of DAP did not uniformly in-
crease the hybridization stability for all target-probe du-
plexes, even moderate incorporation of DAP (1:1 DAP:A)
resulted in signal intensity increases (up to 30-fold) for
the majority of probes on our platform. More important-
ly, a significant number of probes that went previously
Figure 6
Effect of partial DAP substitution on the variability and magnitude of differential expression ratios. (A and B) CVs of the ratios
plotted as a function of the mean ratio for unmodified (A) and modified (B) samples. Signal outliers, defined as any pair of sig-
nals which were greater than two-fold different in intensity, were removed from all samples. (C) Plot showing the number of
probes having a designated CV across a range of CVs for control and partially DAP-modified cRNA targets. (D) Plot showing
the number of probes having a designated fold change (ratio) across a range of ratios for control and partially DAP-modified
cRNA targets.
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undetected (i.e., below a negative control threshold; [6])
in the control sample exhibited signal intensities above
this threshold in DAP-modified samples. Utilization of
such a modification may prove especially valuable for low
abundant transcripts which may be difficult to quantify
because of weak hybridization kinetics. As shown in Fig-
ures 2B and 2C, the largest increases in signal intensities
occurred for low and medium expressers relative to the
unmodified control sample. It is apparent that the effect
of DAP depends not only on the sequence compositions
of target and probe, but also on the absolute abundance
of specific transcripts in the target sample.
It is of interest to note that the results we report here differ
from those obtained by others [23]. Those studies report-
ed increases in signal intensity for targets containing 5-
methyl UTP while completely substituted targets contain-
ing DAP had the opposite or no effect. Although we can-
not completely account for the disparity of the results, one
key difference in methodology between the studies is that
their group was not able to normalize concentrations for
modified and unmodified ATP targets because of dramatic
differences in cRNA yield. Therefore, mass input of cRNA
target samples were much greater for unmodified samples
compared to the DAP-containing samples. Because the
sample preparation used in this protocol is highly robust
and reproducible [24], we were able to use equivalent
mass inputs of all modified and unmodified targets dur-
ing hybridization, allowing us to present our results quan-
titatively rather than qualitatively. However, we agree that
complete substitution of DAP for adenosine may cause
specificity to decline in certain sequence contexts, which
may limit its usefulness in microarray applications. How-
ever, we have found that reducing the proportion of DAP
incorporated into target samples (e.g., incorporating a 1:1
ratio of DAP:adenosine) is one approach to avoid such de-
creases in specificity. Other factors that may contribute to
the dissimilarity of the results include differences in probe
sequence and size, microarray fabrication/chemistries, la-
beling/detection methods, and the vigorous mixing that is
employed in our microarray experiments. We have previ-
ously shown the dramatic impact of mixing on hybridiza-
tion signal intensities [6]. Presumably, this impact is due
to the effect of three dimensional diffusion of the target
molecules and to the effect on how many probes reach
equilibrium in the hybridization. It is possible that the de-
gree of mixing during the hybridization can affect the
number of probes which show a difference in intensity
Figure 7
Number of above-threshold ratios generated by partially DAP-modified and unmodified target samples. A negative control
threshold was imposed to define the lower limit of detection and was calculated by taking the 80% trimmed mean (top 10% and
bottom 10% of signals removed from the population) of 216 negative control probes and adding three standard deviations to
the mean (99.7% confidence). Embryonic kidney and Burkitt's lymphoma samples were performed in duplicate and data were
screened for probes that displayed above-threshold signal intensities. Kidney to lymphoma ratio calls were calculated using
only above-threshold probe signals with a maximum of four ratios for each probe. The data represent the average of the
number of calls for any two kidney and lymphoma slides +/- standard deviation error bars.
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with substitution of DAP for adenosine as well as the mag-
nitude of this difference. Given these differences, it is not
surprising that our results are not in line with those previ-
ously reported.
The results in our study are in good agreement with previ-
ous reports which include a wide variety of interaction
types, including DNA:DNA, DNA:RNA, and DNA:PNA in-
teractions. [11–13,25]. These studies have shown that
DAP substitution in oligonucleotide probes can increase
thermodynamic affinities as reported directly by increases
in Tm and indirectly through increases in hybridization in-
tensities.
Biophysical considerations in using modified NTPs
Modified nucleotides appear to drive the equilibrium
(particularly for low copy transcripts binding with their
targets) towards duplex formation. These findings suggest
that DAP use could be exploited in RNA samples that are
limited, such as tumor biopsies. Based on our experiments
with extended hybridization times (Figure 3), use of DAP
may prove to be a useful alternative to increase array sen-
sitivity for studies that are unable to generate enough tar-
get to hybridize or are unable to increase hybridization
times because of throughput constraints.
Why do we see differential effects of DAP, MeC, and MeU
on hybridization intensities? The fact that DAP was able to
increase hybridization intensities while MeC and MeU de-
creased hybridization intensities (Figures 2D and 2E) is
interesting in light of the fact that DAP is a purine incor-
porated into an RNA strand while MeC and MeU are pyri-
midines incorporated into an RNA strand. Many studies
have shown that a ribopurine rich strand bound to a de-
oxypyrimidine rich strand has a higher stability than the
corresponding all deoxy strands which, in turn, have a
higher stability than a deoxypurine rich strand bound to a
ribopyrimidine rich strand [26,27]. These differences also
suggest that further studies examining DAP or MeC incor-
poration into first strand cDNA, followed by formation of
a DNA-DNA duplex, may not necessarily show the same
effects as incorporation of these modified nucleotides into
cRNA. Finally, earlier studies have noted that methylation
of cytosines (generating MeC) in ribopolynucleotides sta-
bilizes duplexes to the same extent as substitution of
thymine (MeU) for uracil [28]. Thus, although it is still
surprising that MeC and MeU decrease hybridization in-
tensities, it is not surprising that the magnitude of the ef-
fects generated by MeC and MeU residues are similar.
Could the differential effects of DAP versus MeC or MeU
or the differential effects of DAP on different probe se-
quences also be related to structural consequences? Earlier
studies have shown that DAP, in DNA fragments, can wid-
en the minor groove, as detected by reactivity towards ura-
nyl nitrate or susceptibility to Dnase cleavage [29], and
can relieve compressions in the minor groove associated
with A-tracts [30]. In contrast, NMR and molecular mod-
eling studies of an oligonucleotide duplex containing
MeC have demonstrated that, while this duplex still has a
B-DNA conformation, there are differences in the structur-
al parameters and thermal stability relative to the un-
modified duplex [31]. An earlier study also found, in two
closely related octanucleotide duplexes, that although the
methylated duplexes retained their B-DNA conformation,
different structural and thermal stability effects were seen
[32]. Although these studies have been carried out with
DNA-DNA and not DNA-RNA duplexes, it is possible that
MeC substitution may have different structural conse-
quences than DAP substitution.
We have shown that while complete substitution of DAP
for ATP may cause decreased base mismatch discrimina-
tion in certain sequence contexts, equimolar ratios of ad-
enosine and DAP in cRNA target samples did not have
significant detrimental effects on specificity (Figure 4). Re-
markably, in one sequence context, the DAP modification
enhanced specificity against mismatches. Enhanced spe-
cificity against mismatches has also been observed by oth-
er groups when DAP is incorporated into PNA oligomers
[13] and after C5-(1-propynyl)ation of pyrimidines in
DNA-RNA duplexes [33].
The effect of modified NTPs on differential expression ra-
tios
The use of DAP to increase hybridization signals is sup-
ported by the results that show equivalency of both ratio
calls and ratio variability in 1:1 DAP:A and control sam-
ples (Figures 5 and 6). When all data points are consid-
ered in the differential expression ratio analyses, the two
methods appear equivalent. However, when only those
data points which are above a threshold value [6] are
used, ensuring a higher confidence that these intensities
represent true expression levels and not noise or weak
cross hybridization, the DAP-modified cRNA enabled an
~ 10% increase in the number of ratios that could be gen-
erated (Figure 7). Such increases are critical in order to
sample as many genes as possible in any given microarray
experiment. For example, some investigators have ana-
lyzed only data for which the signal intensity is greater
than approximately 0.4% of the total signal range in both
channels [34]. Although this method minimizes the vari-
ance associated with the ratios, many genes and their ex-
pression changes are missed. Other platforms use a
minimal intensity level to determine whether a gene is
present or absent, prior to including this gene in expres-
sion analyses [35]. It is plausible that DAP modification,
by increasing intensity levels, particularly for low ex-
pressors, could enable wider coverage in genome-wide ex-
pression analyses.BMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
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In summary, incorporation of modified nucleotides may
not only lead to discovery and better quantitation of rare
expressers in complex samples but also impact other as-
pects of the microarray experiment such as probe design
prior to array fabrication and the statistical design of
microarray experiments. The target preparation procedure
(generation of amplified cRNA or of first strand cDNA)
and the subsequent duplex formation may dictate the
choice of which modified nucleotide to use, as we and
others have found differential effects with various nucle-
otides. We believe further investigation in this area could
be fruitful.
Methods
Target preparation
Five µgs of human embryonic kidney or Burkitt's lympho-
ma total RNA (Ambion, Inc., Austin, TX) were added to a
reaction mix in a final volume of 12 µl, containing 0.5
pmol T7-(dT)24 oligonucleotide primer. The mixture was
incubated for 10 minutes at 70°C and chilled on ice. With
the mixture remaining on ice, 4 µl of 5X first-strand buffer,
2 µl 0.1 M DTT, 1 µl of 10 mM dNTP mix and 1 µl Super-
script™ II RNaseH- reverse transcriptase (200 U/µl) was
added to make a final volume of 20 µl, and the mixture in-
cubated for one hour in a 42°C water bath. Second-strand
cDNA was synthesized in a final volume of 150 µl, in a
mixture containing 30 µl of 5X second-strand buffer, 3 µl
of 10 mM dNTP mix, 4 µl of E. coli DNA polymerase I (10
U/µl) and 1 µl of RNase H (2 U/µl) for 2 hours at 16°C.
The cDNA was purified using a Qiagen QIAquick purifica-
tion kit, dried down, and resuspended in IVT reaction mix,
containing 3.0 µl nuclease-free water, 4.0 µl 10X reaction
buffer, 4.0 µl 75 mM ATP, 4.0 µl 75 mM GTP 3.0 µl 75
mM CTP, 3.0 µl 75 mM UTP, 7.5 µl 10 mM Biotin-11-
CTP, 7.5 µl 10 mM Biotin 11-UTP and 4.0 µl enzyme mix
(unmodified control condition). Commercially available
2-aminoadenosine-5'-triphosphate, 5-methylcytidine-5'-
triphosphate, and 5-methyluridine-5'-triphosphate
(TriLink Biotechnologies, Inc., San Diego, CA) were sub-
stituted for ATP, CTP, and UTP, respectively, in separate
reactions containing either complete substitution, 1:1, or
1:3 ratio of modified: unmodified NTP, keeping molar in-
put of nucleotide constant. The reaction mix was incubat-
ed for 14 hours at 37°C and cRNA target purified using an
RNeasy® Kit (Qiagen). cRNA yield was quantitated by
measuring the UV absorbance at 260 nm, and fragmented
in 40 mM Tris-acetate (TrisOAc), pH 7.9, 100 mM KOAc,
and 31.5 mM MgOAc, at 94°C, for 20 minutes. This typi-
cally resulted in fragmented target with a size range be-
tween 100–200 bases.
Array hybridization
Two µg of fragmented target cRNA was used for hybridiza-
tion of each UniSet Human I Expression Bioarray (Mo-
torola Life Sciences) containing 9589 probes
(representing 9,203 unique accession numbers (genes),
corresponding to approximately 8,935 unique clusters
and 386 control probes, selected initially from GenBank
Unigene build #125) or for hybridization to a microarray
containing probes corresponding to 1100 human genes,
each spotted 6 times per array. All probes on these micro-
arrays are 30-mer oligonucleotides spotted by piezoelec-
tric technologies and covalently attached to a polymeric
matrix [6]. These microarrays were hybridized, washed,
and processed using a direct detection method of the bi-
otin-containing transcripts by a Streptavidin-Alexa647
conjugate as previously described [6]. Processed slides
were scanned using an Axon GenePix Scanner with the la-
ser set to 635 nm, a PMT voltage of 600, and a scan reso-
lution of 10 microns.
Data analysis
Slides were scanned and images for each slide were quan-
titated using CodeLink Scanning and Analysis Software
(Motorola Life Sciences). Signal intensities for each spot
were calculated by summation of the pixel intensities for
each spot, followed by local background subtraction
(based on the median pixel intensity of the area surround-
ing each spot). Whole array data normalization, when
used, was performed independently for each slide by di-
viding each spot's intensity (after background subtrac-
tion) by the median signal intensity of all test probes. All
false positives, determined by visual inspection of the im-
ages, which were greater than 2-fold different between du-
plicate arrays were removed.
Digestion and chromatography of cRNA
Four units of P1 nuclease were used to digest 20–50 µg of
cRNA to generate nucleotide monophosphates. The en-
zyme was incubated with the cRNA at 55°C for 6 hours,
then for 6 hours at 37°C in the presence of 10 units of calf
intestine alkaline phosphatase to generate the nucleo-
sides. The digested products were purified using Microcon
YM-3 columns followed by centrifugation at 8000 g for
30–60 minutes. The mix was then concentrated using a
SpeedVac to 100 µl. This solution was analyzed on an
HPLC column equilibrated with 0.03 M TEAA (Solvent A)
at a flow rate of 1 ml/min. The following gradient was
used: 0–1% Solvent B (95% AcCN, 5% Solvent A1) over 5
minutes, 1–15% Solvent B over the next 15 minutes, 15–
45% Solvent B over the next 30 minutes, 45–100% Sol-
vent B over the next 20 minutes, and hold at 100% B for
2 minutes. The concentration of the heterocycles was de-
termined by the absorbance values at 260 nm (the wave-
length where maximal absorption occurs for the
heterocycles) and the biotin-containing nucleoside con-
centrations were determined by the absorbance values at
294 nm (the wavelength where maximal absorption oc-
curs for biotinylated cytosine and biotinylated uridine).
The biotin-11-UTP peak was measured at an absorbanceBMC Biotechnology 2002, 2 http://www.biomedcentral.com/1472-6750/2/14
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of 294 nm with the extinction coefficient = 13000 M-1cm-
1. The 2-amino ATP was measured at an absorbance of
260 nm with the extinction coefficient = 9894 M-1cm-1.
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